Highlights and Quick Summary
- EPS (Diluted, from Cont. Ops) for the quarter ending September 30, 2023 was $0.279 (a 54.34% increase compared to previous quarter)
- Year-over-year quarterly EPS (Diluted, from Cont. Ops) decreased by -177.15%
- Annual EPS (Diluted, from Cont. Ops) for 2022 was $-2.1 (a 7.57% increase from previous year)
- Annual EPS (Diluted, from Cont. Ops) for 2021 was $-1.95 (a 0.85% increase from previous year)
- Annual EPS (Diluted, from Cont. Ops) for 2020 was $-1.93 (a 23.05% increase from previous year)
- Twelve month EPS (Diluted, from Cont. Ops) ending September 30, 2023 was $-0.562 (a -58.51% decrease compared to previous quarter)
- Twelve month trailing EPS (Diluted, from Cont. Ops) decreased by -73.23% year-over-year
Trailing EPS (Diluted, from Cont. Ops) for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-0.562 | $-1.35 | $-2.14 | $-2.1 |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted, from Cont. Ops) of ARAVIVE, INC
Most recent EPS (Diluted, from Cont. Ops)of ARAV including historical data for past 10 years.Interactive Chart of EPS (Diluted, from Cont. Ops) of ARAVIVE, INC
ARAVIVE, INC EPS (Diluted, from Cont. Ops) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | $0.0 | $0.0 | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2017 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2014 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2013 | $0.0 | $0.0 | $0.0 | $0.0 | $-0.0 |
| 2012 | – | – | – | – | $-0.0 |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology